A Pharmacokinetic, Pharmacodynamic, and Drug-Drug Interaction Study of Evacetrapib With Selected Statins in Healthy Chinese Subjects
Phase of Trial: Phase I
Latest Information Update: 12 Oct 2018
Price : $35 *
At a glance
- Drugs Evacetrapib (Primary) ; Atorvastatin; Simvastatin
- Indications Atherosclerosis; Cardiovascular disorders; Dyslipidaemias
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 07 Jan 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 09 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 17 Nov 2014 Planned End Date changed from 1 Feb 2015 to 1 Dec 2014 as reported by ClinicalTrials.gov record.